InvestorsHub Logo
Followers 0
Posts 41
Boards Moderated 0
Alias Born 03/04/2017

Re: GreenGenie post# 5128

Tuesday, 04/03/2018 8:53:07 AM

Tuesday, April 03, 2018 8:53:07 AM

Post# of 6773
Deals with Nivaura and Premfina have Taken Form

Pure genious! On 10-16-18, The GreenGenie posted this:

While HLIX is passing all these 5 situations as more clarity surfaces, as reflected in the stock price too, I find Point #5 Particularly Interesting

********
Source Citation and link is Located inside Fiefdom Masada
********

I won't go into all the details of point #5, except for this particular excerpt paraphrased, which is absolutely true the more I ponder it. And also a terrible blow to Alan Brockman's case, explaining why he has missed this 1500% runup thus far.

PARAPHRASED QUOTE: "In 3 to 5 years, cannabis will be taken off the controlled schedule list. On that day large publicly traded companies backed by institutional finance will have a clear pathway into cannabis. Most of those companies are not going to go through the pain of establishing their own company from ground up. They are going to target the most established brands and they are going to buy them at valuations significantly overrepresent the current revenues of those companies. They are going to find a way to get to the front of the line because that's where they like to be and they have the cash to do it. The aquisiton market on that day for well-branded will be a huge win for investors that looked beyond revenues."

__________________________________________________________

Being that I am in the Masada Underground myself, I do have the key to this source:


Post 5128 Source Citation

http://investorshub.advfn.com/boards/read_msg.aspx…

Source Citation for above link:

https://www.joomag.com/…/cannainvestor…/M0367128001460078511

Page 85. Registration with this magazine is free.

About the author of this article:
http://cfobend.com/


_______________________________________________________________

Zachary has proven himself the genius of frontier markets. Starting at ground zero with Blue Line Protection, which I believe is still under 5 cents last I looked, he has built a company with $4.5M in revenue, and what BioTrack will do to that in the revenue/share mix is pure speculation. He has not diluted HLIX of any significance, yet what he did do seems accredtive from my vantage point. He has done nothing but built shareholder value, never putting a value on his company.

There are some lawsuits that give pause, but that's the nature of the beast. The lawsuit against the previous acquisition implies a some revenue was "cooked" and not recurring, but overall lots of dust to clear. To me, I can't see any wrongdoing in just doing dollar-cost averaging as things have gotten more convoluted. Not such a no-brainer that it was when Alan got involved, missing the boat completely, back at 75 cents two years ago when someone handed this gem to him on a silver platter.

So when you said it's a terrible blow to Brockan's case, explaining why he has missd a 1500% runup on HLIX, such folly still eludes him. And he's supposed to be the "expert" opinion (cough, choke).

This company may have some interesting metrics at this time next year, such as a p/s of 10 at the current p. The article that eludes the resident "expert" talks about "In 3 to 5 years" and it's been just two years since this genius I'm responding to made this post. Whew! It's like, how could they not see it? Are they blind?? ARE THEY BLIND AND DEAF? Yes, they can't see what is right in front of their face if it came up and slapped them by MASADA themselves. Especially if dealing with the Keystone Cops.

But lawsuits, setbacks, Trump's untimely election, and things happen, and that's life. So, dollar-cost averaging. How can you go wrong? Seems like these strategies were talked about before if one takes the time to read every post here starting 3 years back, starting at post one. Not even 3/5 of a minimum-hold time for incubation, which HLIX has far exceeded.

What excites me most about HLIX is not just any one thing, but the culimination of Zachary and Ogur -- a team that does a lot and talks little. BioTrack is a big company, and HLIX is built a lot of brand recognition. More and more, speculation from 3 years ago is proving true on who the market leader. People like Alan that never heard of these little seeds now hide, unable to explain why their presnse is getting so loud and undeniable market penetration. Interesting, but not surprisingly, a few posts prior, Alan endorses the acquisition company that's being sued for fraud, and he implies that it's HLIX, the market leader, that's the fraudster. Always, upside down, clueless and useless in his advice.

It is this quote above, which rang true then, and rings true even louder: Most of those companies are not going to go through the pain of establishing their own company from ground up. They are going to target the most established brands and they are going to buy them at valuations significantly overrepresent the current revenues of those companies

Undeniable truth. Truth always comes out in the shake.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.